GGrantIndex
Sort

48,018 grants matching immunotherapy

Structural biophysics and molecular design in cellular immunity

$422,550
Brian M Baker · University Of Notre Dame · R35 · FY2022 · GM

Structural biophysics and molecular design in cellular immunity

$422,550
Brian M Baker · University Of Notre Dame · R35 · FY2025 · GM

Structural biophysics and molecular design in cellular immunity

$422,550
Brian M Baker · University Of Notre Dame · R35 · FY2024 · GM

Transfusion Biology and Medicine

$422,532
Leslie Eric Silberstein · Boston Children'S Hospital · T32 · FY2006 · HL

Eastern Cooperative Oncology Group Studies

$422,458
Case Western Reserve University · U10 · FY2004 · CA

Michigan Center for Translational Cancer Proteogenomics

$422,424
Alexey I Nesvizhskii · University Of Michigan At Ann Arbor · U24 · FY2025 · CA

Exploiting Integrin Signaling to Overcome Resistance to Immunotherapy

$422,422
David G Denardo · Washington University · R01 · FY2024 · CA

Regulation of Tumor Oxygenation by BACH1 in Breast Cancer

$422,410
Marsha R Rosner · University Of Chicago · R01 · FY2022 · CA

CD4 Immune Reconstitution in SIV Infection

$422,404
Francois J Villinger · Emory University · R01 · FY2007 · HL

Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer

$422,350
William J Aronson · University Of California Los Angeles · R01 · FY2022 · CA

Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients

$422,346
Philip Abbosh · Research Inst Of Fox Chase Can Ctr · U01 · FY2021 · CA

Adoptive Immunotherapy for Multiple Myeloma Using Educated T Cells

$422,305
Donald W. Kufe · Dana-Farber Cancer Inst · P01 · FY2014 · CA

Metabolic Control of Innate and Adaptive Immunity in Breast Cancer

$422,302
Guangyong Peng · Saint Louis University · R01 · FY2022 · CA

HLA II PRESENTATION OF ANTIGENS FOR VACCINE

$422,289
Rongfu Wang · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA

ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas

$422,252
David M. Ashley · Duke University · R01 · FY2022 · CA

Development and use of nanoFACS for analysis and sorting of nanoparticles

$422,249
Jennifer Jones · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

ALL immunobiology and the bone marrow niche

$422,227
Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Engineering HIV-specific T cells that have improved function and persistence

$422,189
E. John Wherry · University Of Pennsylvania · U19 · FY2024 · AI

EASTERN COOPERATIVE ONCOLOGY GROUP

$422,179
University Of Pennsylvania · U10 · FY2003 · CA

Engineered Ensemble Nanoimmunotherapies for Cancer

$422,156
Rohan Fernandes · George Washington University · R37 · FY2020 · CA

Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients

$422,144
Philip Abbosh · Research Inst Of Fox Chase Can Ctr · U01 · FY2025 · CA

Role of exosomal SPHK1 in ovarian cancer progression

$422,127
Sunila Pradeep · Medical College Of Wisconsin · R01 · FY2024 · CA

Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface

$422,043
Forest M White · Massachusetts Institute Of Technology · U54 · FY2024 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$422,042
Vanderbilt University · U10 · FY2001 · CA

Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody

$422,003
Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · NS